349 related articles for article (PubMed ID: 25727144)
1. Glycosylation and cancer: moving glycomics to the forefront.
Drake RR
Adv Cancer Res; 2015; 126():1-10. PubMed ID: 25727144
[TBL] [Abstract][Full Text] [Related]
2. Glycosylation characteristics of colorectal cancer.
Holst S; Wuhrer M; Rombouts Y
Adv Cancer Res; 2015; 126():203-56. PubMed ID: 25727149
[TBL] [Abstract][Full Text] [Related]
3. Altered glycosylation in prostate cancer.
Drake RR; Jones EE; Powers TW; Nyalwidhe JO
Adv Cancer Res; 2015; 126():345-82. PubMed ID: 25727153
[TBL] [Abstract][Full Text] [Related]
4. Glycans as cancer biomarkers.
Adamczyk B; Tharmalingam T; Rudd PM
Biochim Biophys Acta; 2012 Sep; 1820(9):1347-53. PubMed ID: 22178561
[TBL] [Abstract][Full Text] [Related]
5. The Complexity and Dynamics of the Tissue Glycoproteome Associated With Prostate Cancer Progression.
Kawahara R; Recuero S; Srougi M; Leite KRM; Thaysen-Andersen M; Palmisano G
Mol Cell Proteomics; 2021; 20():100026. PubMed ID: 33127837
[TBL] [Abstract][Full Text] [Related]
6. Glycosylation and its implications in breast cancer.
Scott DA; Drake RR
Expert Rev Proteomics; 2019 Aug; 16(8):665-680. PubMed ID: 31314995
[No Abstract] [Full Text] [Related]
7. The Repertoire of Glycan Alterations and Glycoproteins in Human Cancers.
Kori M; Aydin B; Gulfidan G; Beklen H; Kelesoglu N; Caliskan Iscan A; Turanli B; Erzik C; Karademir B; Arga KY
OMICS; 2021 Mar; 25(3):139-168. PubMed ID: 33404348
[TBL] [Abstract][Full Text] [Related]
8. Human disease glycomics: technology advances enabling protein glycosylation analysis - part 1.
Everest-Dass AV; Moh ESX; Ashwood C; Shathili AMM; Packer NH
Expert Rev Proteomics; 2018 Feb; 15(2):165-182. PubMed ID: 29285957
[TBL] [Abstract][Full Text] [Related]
9. Mass Spectrometry-Based N-Glycomics of Colorectal Cancer.
Sethi MK; Fanayan S
Int J Mol Sci; 2015 Dec; 16(12):29278-304. PubMed ID: 26690136
[TBL] [Abstract][Full Text] [Related]
10. In-depth N-glycome profiling of paired colorectal cancer and non-tumorigenic tissues reveals cancer-, stage- and EGFR-specific protein N-glycosylation.
Sethi MK; Kim H; Park CK; Baker MS; Paik YK; Packer NH; Hancock WS; Fanayan S; Thaysen-Andersen M
Glycobiology; 2015 Oct; 25(10):1064-78. PubMed ID: 26085185
[TBL] [Abstract][Full Text] [Related]
11. A glycomics approach to the discovery of potential cancer biomarkers.
An HJ; Lebrilla CB
Methods Mol Biol; 2010; 600():199-213. PubMed ID: 19882130
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive glycomics comparison between colon cancer cell cultures and tumours: implications for biomarker studies.
Chik JH; Zhou J; Moh ES; Christopherson R; Clarke SJ; Molloy MP; Packer NH
J Proteomics; 2014 Aug; 108():146-62. PubMed ID: 24840470
[TBL] [Abstract][Full Text] [Related]
13. Cancer glycomics offers potential biomarkers and therapeutic targets in the framework of 3P medicine.
Guo Y; Jia W; Yang J; Zhan X
Front Endocrinol (Lausanne); 2022; 13():970489. PubMed ID: 36072925
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a combined glycomics and glycoproteomics approach for studying the major glycoproteins present in biofluids: Application to cerebrospinal fluid.
Goyallon A; Cholet S; Chapelle M; Junot C; Fenaille F
Rapid Commun Mass Spectrom; 2015 Mar; 29(6):461-73. PubMed ID: 26160412
[TBL] [Abstract][Full Text] [Related]
15. Unique to this volume is the subsequent focus of individual chapters on what is known about glycosylation in relation to specific organ sites of cancer. Preface.
Drake RR; Ball L
Adv Cancer Res; 2015; 126():xiii-xiv. PubMed ID: 25727154
[No Abstract] [Full Text] [Related]
16. Sweet systems: technologies for glycomic analysis and their integration into systems biology.
Chen S; Qin R; Mahal LK
Crit Rev Biochem Mol Biol; 2021 Jun; 56(3):301-320. PubMed ID: 33820453
[TBL] [Abstract][Full Text] [Related]
17. Altered glycosylation in cancer: A promising target for biomarkers and therapeutics.
Thomas D; Rathinavel AK; Radhakrishnan P
Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188464. PubMed ID: 33157161
[TBL] [Abstract][Full Text] [Related]
18. The clinical role of glycobiology on ovarian cancer progression.
Armbrister R; Ochoa L; Abbott KL
Adv Cancer Res; 2023; 157():1-22. PubMed ID: 36725106
[TBL] [Abstract][Full Text] [Related]
19. Cellular O-Glycome Reporter/Amplification (CORA): Analytical and Preparative Tools to Study Mucin-Type O-Glycans of Living Cells.
Kudelka MR; Li Z; Chernova TA; Smith DF; Song X; Cummings RD; Ju T
Curr Protoc; 2021 Jun; 1(6):e142. PubMed ID: 34101390
[TBL] [Abstract][Full Text] [Related]
20. Functional impact of tumor-specific N-linked glycan changes in breast and ovarian cancers.
Guo H; Abbott KL
Adv Cancer Res; 2015; 126():281-303. PubMed ID: 25727151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]